Veropharm

Veropharm is a leading Russian pharmaceutical manufacturer that specializes in the development and production of generic drugs, medical devices, and adhesive bandages. Founded in 1997, the company has grown to become one of the largest domestic producers of oncology medications in Russia, operating multiple GMP-certified manufacturing facilities. Its portfolio includes a wide range of cytostatic agents used in the treatment of various cancers, as well as products for gastroenterology and dermatology. In 2014, Veropharm was acquired by Abbott Laboratories, a move that significantly expanded Abbott's manufacturing presence and established pharmaceutical business in the Russian market. The company continues to operate as a subsidiary of Abbott, focusing on providing affordable, high-quality healthcare solutions to patients in Russia and the CIS region.